Sign inJoin waitlistJoin the waitlist

Adrienne Hammill

Research Director · Cincinnati Children's Hospital Medical Center

Credentials: · · · · ·

History

Cincinnati Children's Hospital Medical Center
Present
Cincinnati Children's Hospital Medical Center
Present

Pediatric Hematology-Oncology
Cincinnati Children's Hospital Medical Center
2007–2008
Pediatrics
Cincinnati Children's Hospital Medical Center
2004–2007
Univ of Texas Southwestern Med Sch at Dallas
2000–2004

Research

Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
PEDIATRICS · 2016 · 647 citations
Sirolimus for the treatment of complicated vascular anomalies in children
Pediatric Blood & Cancer · 2011 · First of 9 authors · Corresponding · 451 citations
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia
Annals of Internal Medicine · 2020 · 425 citations

Denise Adams
23 papers
Anusua Dasgupta
12 papers
MP
Manish Patel
10 papers
Anne Comi
9 papers
Kiersten Ricci
9 papers
Ionela Iacobas
8 papers
AM
Arnold Merrow
6 papers · 1 as a fellow
Raj Kasthuri
6 papers
AP
Anna Pinto
5 papers · 3 as a fellow
CT
Cameron Trenor
5 papers
Carol Chute
5 papers
Hanny Al-Samkari
5 papers

Clinical trials

Effect of Laser Treatment on Capillary Malformations
Principal investigator · Withdrawn
Children's Hospital Medical Center, Cincinnati
2014–2017
Ontogeny of Infantile Hemangiomas With Skin Imaging Modalities
Principal investigator · Completed
Children's Hospital Medical Center, Cincinnati
2011–2015
EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals
2025–2030
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Site PI · Recruiting · Phase 2, Phase 3
Novartis Pharmaceuticals
2023–2033